YLYi Liu

Yi Liu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yi Liu has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Lin-Lin Hu

    Sleep Medicine Center, Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou, China

    1 shared publication
  • Long Zhang

    Molecular Biology Laboratory, Hangzhou Seventh People's Hospital, 305 Tianmushan Road, Hangzhou, Zhejiang 310013, China

    1 shared publication
  • Mingfen Song

    Affiliated Mental Health Centre & Hangzhou Seventh People's Hospital, Zhejiang University School of Medicine, 310013 Hangzhou, Zhejiang, China

    1 shared publication
  • Shengdong Wang

    The Molecular Biology Laboratory, Hangzhou Seventh People’s Hospital, Hangzhou, China

    1 shared publication
  • Ting-Ting Wang

    Department of Anesthesiology and Pain Medicine, The First Affiliated Hospital of Jiaxing University, Jiaxing, 314001, PR China; The Second Clinical Medical College, Zhejiang Chinese Medicine University, Hangzhou, PR China

    1 shared publication
  • Wenjuan Liu

    Affiliated Mental Health Center & Hangzhou Seventh People’s Hospital, Zhejiang University School of Medicine, China

    1 shared publication

Latest Publications

  • Open Access

    Modified Suanzaorentang Had the Treatment Effect for Generalized Anxiety Disorder for the First 4 Weeks of Paroxetine Medication: A Pragmatic Randomized Controlled Study

    by Ming-Fen Song, Lin-Lin Hu, Wen-Juan Liu, Yi Liu, Xiao-Yun Tao, Ting-Ting Wang, Sheng-Dong Wang, Long Zhang, Yong-Hua Zhang

    Background. Paroxetine does not show satisfactory therapeutic effect for generalized anxiety disorder (GAD) patients for the first 2–4 weeks of medication. Diazepam is always concurrently used although it has some shortcomings such as physical dependence and withdrawal reactions. In this study, we aimed to identify whether modified Suanzaorentang (MSZRT), a combined Chinese formula including Suanzaorentang (SZRT) and Zhizichitang (ZZCT), could control the anxiety of GAD for the first 4 weeks of paroxetine medication. Methods. 156 GAD patients were randomized to the treatment of paroxetine, paroxetine‐diazepam, or paroxetine‐MSZRT for 4 weeks. Hamilton Anxiety Scale (HAMA) Test and Self‐Rating Anxiety Scale (SAS) Test were determined each week as the evaluation of clinical efficacy. Adverse events (AEs) were also closely observed by performing the Treatment Emergent Symptom Scale (TESS) Test. Results. Both paroxetine‐MSZRT and paroxetine‐diazepam decreased more HAMA and SAS total scores than paroxetine from weeks 1 to 3. Paroxetine‐MSZRT as well as paroxetine‐diazepam had an obviously higher onset rate than paroxetine in each week. After 4 weeks’ treatment, the overall effectiveness rate in the paroxetine‐MSZRT group (90.00%) was obviously higher than those of the paroxetine group (74.42%) but did not significantly differ from the paroxetine‐diazepam group (93.88%). Conclusion. MSZRT had the treatment effect for GAD when paroxetine was used for the first 4 weeks.